<!DOCTYPE html>
<html>
  <head>
  <script>
  var gData;
  function onBodyLoad(){
  		//writeSummary1();
  }
  
    function replaceChar(char){
        var temp, returnVal;
        if (char == "0")
            returnVal = "-"
        else if (char == "")
            returnVal = "-"
        else
            returnVal = char;
        return returnVal;
    }
    
    function isIncomeRider(amt,rider){
		//rider.replace(/^\s+|\s$/g,"")
		//$.trim(rider)
		var temp;
		temp = $.trim(rider)
		//alert(temp + "x")
        if (temp == "HLA Income Builder" || temp == "Income 20 Rider" || temp == "Income 30 Rider" || temp == "Income 40 Rider" || temp == "Income D-20 Rider" || temp == "Income D-30 Rider" || temp == "Income D-40 Rider" || temp == "Income E-20 Rider" || temp == "Income E-30 Rider"){
        	return amt + " *";
        }
        else
        	return amt + "&nbsp;&nbsp;";
    }
    
  </script>
  <head>
  <body onload="onBodyLoad()">
  
<div id="header">
	<div class="agentInfo">
  		Code : <span id="agentCode" class="agentCode">{agentCode}</span>&nbsp;&nbsp;Prepared By : <span id="agentName" class="agentName">{agentName}</span>  		
  	</div>
  	<div class="ContentInfo">Printed On : <span id="dateModified" class="dateModified">{DateModified}</span></div>
  	<div class="hruleInfo"></div>
</div>
<div class="main-content">
<!--520px-->



<div class="contentArea" style="height:650px;">
    <table cellspacing="3" id="item2B" class="item2B" style="width: 100%">
	<tr style="display:table-row;">
	    <td>&nbsp;</td>
	    <td>
		<table width="100%" border="0" cellspacing="0">
		    <tr>
			<td colspan="2" style="padding: 0px 0px 10px 0px;" class="2B" id="2B"><span id="showOnlyAtFirstPage" class="showOnlyAtFirstPage"></span></td>
			<td width="20"style="padding: 0px 0px 10px 0px;" class="2B" id="2B"><b></b></td>
		    </tr>
			
<table id="table-attachingRider1" class="table-attachingRider1" style="width: 100%">
<tr class="tblHeader" id="tblHeader" style="display:table-row;">
    <th class="contentSmall" style="text-align:left;vertical-align:text-top;width:10%"><b>Rider(s)</b></th>
    <th class="contentSmall" style="text-align:left;vertical-align:text-top;width:5%"><b><b>Sum Assured<br/>/Benefit</b></th>
    <th class="contentSmall" style="text-align:left;vertical-align:text-top;width:5%"><b>Coverage<br/>Period</b></th>
    <th class="contentSmall" style="text-align:left;vertical-align:text-top;width:5%"><b>Insured<br/>Lives</b></th>
    <th class="content" style="vertical-align:text-top;width:75%"><b>Description of Benefits</b></th>
</tr>
    
<!--ACIR_MPP-Accelerated Critical Illness Rider start--> 
<tr class="ACIR_MPP" id="ACIR_MPP" style="display:table-row;">
    <td class="contentSmall">Accelerated<br/>Critical<br/>Illness</br>Rider</td><br/>
    <td class="contentSmall" style="text-align:right;"><span id="ACIR_MPPRiderGYI" class="ACIR_MPPRiderGYI">{ACIR_MPPRiderGYI}</span></td>
    <td class="contentSmall" style="text-align:center;"><span id="ACIR_MPPRiderTerm" class="ACIR_MPPRiderTerm">{ACIR_MPPRiderTerm}</span></td>
    <td class="contentSmall" style="text-align:left;">Life<br/>Assured</td>
    <td class="content">
        RM <span id="ACIR_MPPRiderGYI" class="ACIR_MPPRiderGYI">{ACIR_MPPRiderGYI}</span> is payable upon diagnosis of any of the 36 critical illnesses covered of the life assured during the coverage term. Upon payment of the Rider Sum Assured, the basic policy sum assured will be reduced accordingly.<br/>
        Premium is not guaranteed and is subject to review by the Company at any time and from time to time by giving you at least 90-day written notice.<br/>
        The following 36 critical illnesses are covered:<br/><br/>
        
        <table id="illness" class="illness" style="border-collapse:separate;border: 0px solid black;width: 75%;">
            <tr>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">1.</td>
                <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Stroke</td>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">19.</td>
                <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Loss of Speech</td>
            </tr>
            <tr>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">2.</td>
                <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Heart Attack</td>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">20.</td>
                <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Brain Surgery</td>
            </tr>
            <tr>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">3.</td>
                <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">End Stage Kidney Failure</td>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">21.</td>
                <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Heart Valve Surgery</td>
            </tr>
            <tr>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">4.</td>
                <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Cancer</td>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">22.</td>
                <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Terminal Illness</td>
            </tr>
            <tr>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">5.</td>
                <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Coronary Artery By-Pass Surgery</td>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">23.</td>
                <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">HIV due to Blood Transfusion</td>
            </tr>
            <tr>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">6.</td>
                <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Other Serious Coronary Artery Disease</td>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">24.</td>
                <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Bacterial Meningitis</td>
            </tr>
            <tr>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">7.</td>
                <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;"><sup><span class="fnPage35_ACIR" style="font-size: 5px"></span></sup>Angioplasty and Other Invasive Treatments for Major Coronary Artery Disease</td>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">25.</td>
                <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Major Head Trauma</td>
            </tr>
            <tr>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">8.</td>
                <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">End Stage Liver Failure</td>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">26.</td>
                <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Chronic Aplastic Anemia</td>
            </tr>
            <tr>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">9.</td>
                <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Fulminant Viral Hepatitis</td>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">27.</td>
                <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Motor Neuron Disease</td>
            </tr>
            <tr>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">10.</td>
                <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Coma</td>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">28.</td>
                <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Parkinson's Disease</td>
            </tr>
            <tr>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">11.</td>
                <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Benign Brain Tumor</td>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">29.</td>
                <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Alzheimer's Disease/Irreversible Organic Degenerative Brain Disorders</td>
            </tr>
            <tr>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">12.</td>
                <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Paralysis/Paraplegia</td>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">30.</td>
                <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Muscular Dystrophy</td>
            </tr>
            <tr>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">13.</td>
                <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Blindness /Total Loss of Sight</td>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">31.</td>
                <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Surgery to Aorta</td>
            </tr>
            <tr>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">14.</td>
                <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Deafness/Total Loss of Hearing</td>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">32.</td>
                <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Multiple Sclerosis</td>
            </tr>
            <tr>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">15.</td>
                <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Major Burns</td>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">33.</td>
                <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Primary Pulmonary Arterial Hypertension</td>
            </tr>
            <tr>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">16.</td>
                <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">End Stage Lung Disease</td>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">34.</td>
                <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Medullary Cystic Disease</td>
            </tr>
            <tr>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">17.</td>
                <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Encephalitis</td>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">35.</td>
                <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Severe Cardiomyopathy</td>
            </tr>
            <tr>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">18.</td>
                <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Major Organ / Bone Marrow Transplant</td>
                <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">36.</td>
                <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Systemic Lupus Erythematosus with Lupus Nephritis</td>
            </tr>
        </table>
        
        <br/>
        <span class="fnPage35_ACIR"></span>Benefit payment under this illness is limited to 10% of the Critical Illness coverage under this plan subject to a maximum of RM 25,000. This benefit is payable<br/>
        once only and shall be deducted from the coverage of this plan, thereby reducing the amount of lump sum payment upon Critical Illness.
    </td>
</tr>
<!--ACIR_MPP-Accelerated Critical Illness Rider ends--> 
 
<!--CCTR-Convertible Comprehensive Term Rider start--> 
<tr class="CCTR" id="CCTR" style="display:table-row;">
    <td class="contentSmall">Convertible<br/>Comprehensive<br/>Term<br/>Rider</td>
    <td class="contentSmall" style="text-align:right;"><span id="CCTRRiderGYI" class="CCTRRiderGYI">{CCTRRiderGYI}</span></td>
    <td class="contentSmall" style="text-align:center;"><span id="CCTRRiderTerm" class="CCTRRiderTerm">{CCTRRiderTerm}</span></td>
    <td class="contentSmall" style="text-align:left;">Life<br/>Assured</td>
    <td class="content">
    RM <span id="CCTRRiderGYI" class="CCTRRiderGYI">{CCTRRiderGYI}</span> is payable upon death / TPD (prior to age 65) of the life assured during the coverage term. TPD benefit will be paid in accordance to TPD provision. During the term of the Rider and before attaining age 60, the life assured may convert the policy to a whole life plan or an endowment plan without further evidence of insurability.<br/><br/>
</td>
</tr>
<!--CCTR-Convertible Comprehensive Term Rider end-->

<!--CIR-Critical Illness Rider start--> 
<tr class="CIR" id="CIR" style="display:table-row;">
<td class="contentSmall">Critical<br/>Illness<br/>Rider</td>
<td class="contentSmall" style="text-align:right;"><span id="CIRRiderGYI" class="CIRRiderGYI">{CIRRiderGYI}</span></td>
<td class="contentSmall" style="text-align:center;"><span id="CIRRiderTerm" class="CIRRiderTerm">{CIRRiderTerm}</span></td>
<td class="contentSmall" style="text-align:left;">Life<br/>Assured</td>
<td class="content">
RM <span id="CIRRiderGYI" class="CIRRiderGYI">{CIRRiderGYI}</span> is payable upon diagnosis of any of the 36 critical illnesses covered of the life assured during the coverage term. Premium is not guaranteed and is subject to review by the Company at any time and from time to time by giving you at least 90-day written notice.<br/>
The following 36 critical illnesses are covered:<br/><br/>

<table id="illness" class="illness" style="border-collapse:separate;border: 0px solid black;width: 75%;">
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">1.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Stroke</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">19.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Loss of Speech</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">2.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Heart Attack</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">20.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Brain Surgery</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">3.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">End Stage Kidney Failure</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">21.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Heart Valve Surgery</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">4.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Cancer</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">22.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Terminal Illness</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">5.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Coronary Artery By-Pass Surgery</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">23.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">HIV due to Blood Transfusion</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">6.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Other Serious Coronary Artery Disease</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">24.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Bacterial Meningitis</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">7.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;"><sup><span class="fnPage35_CIR" style="font-size: 5px"></span></sup>Angioplasty and Other Invasive Treatments for Major Coronary Artery Disease</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">25.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Major Head Trauma</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">8.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">End Stage Liver Failure</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">26.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Chronic Aplastic Anemia</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">9.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Fulminant Viral Hepatitis</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">27.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Motor Neuron Disease</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">10.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Coma</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">28.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Parkinson's Disease</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">11.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Benign Brain Tumor</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">29.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Alzheimer's Disease/Irreversible Organic Degenerative Brain Disorders</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">12.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Paralysis/Paraplegia</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">30.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Muscular Dystrophy</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">13.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Blindness /Total Loss of Sight</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">31.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Surgery to Aorta</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">14.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Deafness/Total Loss of Hearing</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">32.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Multiple Sclerosis</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">15.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Major Burns</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">33.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Primary Pulmonary Arterial Hypertension</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">16.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">End Stage Lung Disease</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">34.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Medullary Cystic Disease</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">17.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Encephalitis</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">35.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Severe Cardiomyopathy</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">18.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Major Organ / Bone Marrow Transplant</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">36.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Systemic Lupus Erythematosus with Lupus Nephritis</td>
</tr>
</table>

<br/>
<span class="fnPage35_CIR"></span>Benefit payment under this illness is limited to 10% of the Critical Illness coverage under this plan subject to a maximum of RM 25,000. This benefit is payable<br/>
once only and shall be deducted from the coverage of this plan, thereby reducing the amount of lump sum payment upon Critical Illness.
</td>
</tr>
<!--CIR-Critical Illness Rider end-->

<!--CIWP-Critical Illness WP Rider start--> 
<tr class="CIWP" id="CIWP" style="display:table-row;">
	<td class="contentSmall">Critical<br/>Illness Waiver of Premium<br/>Rider <span id="CIWPPC" class="CIWPPC">{CIWPPC}</span></td>
	<td class="contentSmall" style="text-align:right;"><span id="CIWPRiderGYI" class="CIWPRiderGYI">{CIWPRiderGYI}</span><br/>(Annually)</td>
    <td class="contentSmall" style="text-align:center;"><span id="CIWPRiderTerm" class="CIWPRiderTerm">{CIWPRiderTerm}</span></td>
    <td class="contentSmall" style="text-align:left;">Life<br/>Assured</td>
    <td class="content">
    The Rider Sum Assured will be paid to reduce future premium up to expiry date of the Rider upon diagnosis of any of the 36 critical illnesses covered of the life assured during the coverage period. Premium is not guaranteed and is subject to review by the Company at any time and from time to time by giving you at least 90-day written notice.<br/>
    The following 36 critical illnesses are covered :<br/><br/>
    <table id="illness" class="illness" style="border-collapse:separate;border: 0px solid black;width: 75%;">
    <tr>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">1.</td>
    <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Stroke</td>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">19.</td>
    <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Loss of Speech</td>
    </tr>
    <tr>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">2.</td>
    <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Heart Attack</td>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">20.</td>
    <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Brain Surgery</td>
    </tr>
    <tr>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">3.</td>
    <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">End Stage Kidney Failure</td>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">21.</td>
    <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Heart Valve Surgery</td>
    </tr>
    <tr>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">4.</td>
    <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Cancer</td>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">22.</td>
    <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Terminal Illness</td>
    </tr>
    <tr>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">5.</td>
    <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Coronary Artery By-Pass Surgery</td>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">23.</td>
    <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">HIV due to Blood Transfusion</td>
    </tr>
    <tr>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">6.</td>
    <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Other Serious Coronary Artery Disease</td>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">24.</td>
    <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Bacterial Meningitis</td>
    </tr>
    <tr>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">7.</td>
    <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;"><sup><span class="fnPage35_CIWP" style="font-size: 5px"></span></sup>Angioplasty and Other Invasive Treatments for Major Coronary Artery Disease </td>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">25.</td>
    <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Major Head Trauma</td>
    </tr>
    <tr>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">8.</td>
    <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">End Stage Liver Failure</td>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">26.</td>
    <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Chronic Aplastic Anemia</td>
    </tr>
    <tr>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">9.</td>
    <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Fulminant Viral Hepatitis</td>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">27.</td>
    <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Motor Neuron Disease</td>
    </tr>
    <tr>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">10.</td>
    <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Coma</td>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">28.</td>
    <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Parkinson's Disease</td>
    </tr>
    <tr>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">11.</td>
    <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Benign Brain Tumor</td>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">29.</td>
    <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Alzheimer's Disease/Irreversible Organic Degenerative Brain Disorders</td>
    </tr>
    <tr>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">12.</td>
    <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Paralysis/Paraplegia</td>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">30.</td>
    <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Muscular Dystrophy</td>
    </tr>
    <tr>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">13.</td>
    <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Blindness /Total Loss of Sight</td>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">31.</td>
    <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Surgery to Aorta</td>
    </tr>
    <tr>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">14.</td>
    <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Deafness/Total Loss of Hearing</td>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">32.</td>
    <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Multiple Sclerosis</td>
    </tr>
    <tr>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">15.</td>
    <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Major Burns</td>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">33.</td>
    <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Primary Pulmonary Arterial Hypertension</td>
    </tr>
    <tr>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">16.</td>
    <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">End Stage Lung Disease</td>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">34.</td>
    <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Medullary Cystic Disease</td>
    </tr>
    <tr>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">17.</td>
    <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Encephalitis</td>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">35.</td>
    <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Severe Cardiomyopathy</td>
    </tr>
    <tr>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">18.</td>
    <td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Major Organ / Bone Marrow Transplant</td>
    <td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">36.</td>
    <td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Systemic Lupus Erythematosus with Lupus Nephritis</td>
    </tr>
</table>
<br/>
<span class="fnPage35_CIWP"></span>Benefit payment under this illness is limited to 10% of the Critical Illness coverage under this plan subject to a maximum of RM 25,000. This benefit is payable<br/>
once only and shall be deducted from the coverage of this plan, thereby reducing the benefit payable upon Critical Illness.

</td></tr>
<!--CIWP-Critical Illness WP Rider end-->

<!--CPA-Compprehensive Personal Accident Rider start-->
<tr class="CPA" id="CPA" style="display:table-row;">
<td class="contentSmall">Comprehensive<br/>Personal<br/>Accident<br/>Rider <span id="OCCPClass" class="OCCPClass">{OCCPClass}</span></td>
<td class="contentSmall" style="text-align:right;"><span id="CPARiderGYI" class="CPARiderGYI">{CPARiderGYI}</span></td>
<td class="contentSmall" style="text-align:center;width: 5%"><span id="CPARiderTerm" class="CPARiderTerm">{CPARiderTerm}</span></td>
<td class="contentSmall" style="text-align:left;">Life<br/>Assured</td>
<td class="content">
The following benefits are payable during the coverage period:<br/>
-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accidental Death<br/>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Death due to Accident  â€“ Rider Sum Assured is payable<br/>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Double Indemnity - Rider Sum Assured payable is doubled if accidental death of Life Assured occurred while the Life Assured is on mechanically<br/>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;propelled Public Conveyance over an established route on land, excluding Taxis<br/>
-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total &amp; Permanent Disability due to accident - refer to Schedule of Indemnities in the Rider<br/>
-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Temporary total disability - weekly indemnity of RM8 per RM1,000 sum assured<br/>
-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Temporary partial disability - weekly indemnity of RM2 per RM1,000 sum assured<br/>
-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Medical fees &amp; expenses reimbursement - up to RM20 per RM1,000 sum assured<br/>
-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compassionate Allowance Benefit - RM500 will be payable in one lump sum in the event of death of the Life Assured due to any cause<br/><br/>
<!--CPA-Compprehensive Personal Accident Rider end-->

<!--EDB-Enchanced Death Benefit Rider start-->
<tr class="EDB" id="EDB" style="display:table-row;">
<td class="contentSmall">Enchanced<br/>Death<br/>Benefit<br/>Rider</td>
<td class="contentSmall" style="text-align:right;"><span id="EDBRiderGYI" class="EDBRiderGYI">{EDBRiderGYI}</span></td>
<td class="contentSmall" style="text-align:center;"><span id="EDBRiderTerm" class="EDBRiderTerm">{EDBRiderTerm}</span></td>
<td class="contentSmall" style="text-align:left;">Life<br/>Assured</td>
<td class="content">
In the event of Death of the Life Assured, a lump sum amount equivalent to RM<span id="EDBGYI" class="EDBGYI">{EDBGYI}</span> shall be payable. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br/>
Juvenile LIEN rule is applicable.
</td>
</tr>
<!--EDB-Enchanced Death Benefit Rider end-->

    
<!--EDUWR-Edu Wealth Rider starts--> 
<tr class="EDUWR" id="EDUWR" style="display:table-row;">
    <td class="contentSmall">EduWealth<br/>Rider</td>
    <td class="contentSmall" style="text-align:right;"><span id="EDUWRGYI" class="EDUWRGYI">{EDUWRGYI}</span></td>
    <td class="contentSmall" style="text-align:center;"><span id="EDUWRTerm" class="EDUWRTerm">{EDUWRTerm}</span></td>
    <td class="contentSmall" style="text-align:left;">Life<br/>Assured</td>
    <td class="content">
        <b><u>Death/TPD Benefit</u></b><br/>
        In the event of Death/TPD (prior to attaining age 65) of the Life Assured, the Death/TPD benefit payable shall be 100% of premium paid for this Rider (exclude any loading premium) calculated based on an annual mode of payment, accumulated GCP (if any), accumulated Cash Dividend (if any) and Special Terminal Dividend (if any).<br/>
        
        TPD benefit will be paid in accordance to TPD provision as illustrated under Descriptions of Basic Plan Benefits. <br/><br/>
        
        <b><u>Guaranteed Cash Payment (GCP) Benefit</u></b><br/>
        Guaranteed Cash Payments of RM <span id="EDUWRGYI" class="EDUWRGYI">{EDUWRGYI}</span> is payable annually at the end of the last 4 rider years.
        
    </td>
</tr>
<!--EDUWR-Edu Wealth Rider ends-->  

<!--ETPDB-Enchanced TPD Benefit Rider start-->
<tr class="ETPDB" id="ETPDB" style="display:table-row;">
<td class="contentSmall">Enchanced<br/>TPD Benefit<br/>Rider</td>
<td class="contentSmall" style="text-align:right;"><span id="ETPDBRiderGYI" class="ETPDBRiderGYI">{ETPDBRiderGYI}</span></td>
<td class="contentSmall" style="text-align:center;"><span id="ETPDBRiderTerm" class="ETPDBRiderTerm">{ETPDBRiderTerm}</span></td>
<td class="contentSmall" style="text-align:left;">Life<br/>Assured</td>
<td class="content">
In the event of Total and Permanent Disability prior to attaining age 65 (TPD) or Old Age Disablement after attaining age 65 (OAD) of the Life Assured, a lump sum amount equivalent to RM<span id="ETPDBGYI" class="ETPDBGYI">{ETPDBGYI}</span> be payable. Juvenile LIEN rule is applicable. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br/>
<u>Provision for TPD Benefit</u><br/>
TPD Benefit will be paid in accordance to TPD provision as below:<br/><br/>
    <table id="illness" class="illness" style="border-collapse:collapse;border: 1px solid black;width: 50%;" >
	<tr>
	    <td width="50%" style="text-align:center;">Attained Age upon TPD</td>
	    <td width="50%" style="text-align:center;">TPD Benefit Limit per Life</td>
	</tr>
	<tr>
	    <td style="text-align:center;">Less than 7</td>
	    <td style="text-align:center;">RM100,000</td>
	</tr>
	<tr>
	    <td style="text-align:center;">7 to less than 15</td>
	    <td style="text-align:center;">RM500,000</td>
	</tr>
	<tr>
	    <td style="text-align:center;">15 to less than 65</td>
	    <td style="text-align:center;">RM3,500,000</td>
	</tr>
    </table>
    <br/>
Total TPD Benefits per Life payable under all policies insuring the Life Assured shall not exceed the TPD Benefit Limit per Life stated above.<br/>
The Total TPD Benefit per Life refers to TPD coverage of all in force policies for <u>each Life Assured</u> at the point of claim event after applications of Juvenile Lien.<br/><br/>
<u>Provision for OAD Benefit</u><br/>
OAD Benefits payable under all policies insuring the Life Assured shall limit to RM1,000,000 per life. OAD Benefit Limit per Life is determined by OAD coverage<br/>
of all in-force policies for <u>each Life Assured</u> at the point of claim event.<br/><br/>
Note: TPD refers to Total & Permanent Disability prior to attaining age 65 and OAD refers to Old Age Disablement after attaining age 65. These definitions<br/>
apply consistently across all marketing collaterals for Enhanced TPD Benefit Rider.


</td>
</tr>
<!--ETPDB-Enchanced TPD Benefit Rider end-->

<!--HB-Hospitalisation Benefit start-->
<tr class="HB" id="HB" style="display:table-row;">
<td class="contentSmall">Hospitalisation<br/>Benefit Rider</td>
<td class="contentSmall" style="text-align:right;"><span id="HBRiderGYI" class="HBRiderGYI">{HBRiderGYI}</span></td>
<td class="contentSmall" style="text-align:center;"><span id="HBRiderTerm" class="HBRiderTerm">{HBRiderTerm}</span></td>
<td class="contentSmall" style="text-align:left;">Life<br/>Assured</td>
<td class="content">
Hospitalisation benefit of RM <span id="HBBenefit" class="HBBenefit">{HBBenefit}</span> per week is payable if the life assured is hospitalised during the coverage period. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</td>
</tr>
<!--HB-Hospitalisation Benefit end-->

<!--ICR-Income Care Rider start-->
<tr class="ICR" id="ICR" style="display:table-row;">
<td class="contentSmall">IncomeCare Rider</td>
<td class="contentSmall" style="text-align:right;"><span id="ICRRiderGYI" class="ICRRiderGYI">{ICRRiderGYI}</span></td>
<td class="contentSmall" style="text-align:center;"><span id="ICRRiderTerm" class="ICRRiderTerm">{ICRRiderTerm}</span></td>
<td class="contentSmall" style="text-align:left;">Life<br/>Assured</td>
<td class="content">
Upon TPD or diagnosis of any 36 critical illness of the life assured during the coverage period and the life assured remains disabled, RM <span id=""ICRGYI class="ICRGYI">{ICRGYI}</span> shall be payable annually up to age 65 or death of the life assured, whichever is earlier. The following 36 critical illnesses are covered: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br/>

<table id="illness" class="illness" style="border-collapse:separate;border: 0px solid black;width: 75%;">
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">1.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Stroke</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">19.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Loss of Speech</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">2.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Heart Attack</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">20.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Brain Surgery</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">3.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">End Stage Kidney Failure</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">21.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Heart Valve Surgery</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">4.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Cancer</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">22.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Terminal Illness</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">5.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Coronary Artery By-Pass Surgery</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">23.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">HIV due to Blood Transfusion</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">6.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Other Serious Coronary Artery Disease</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">24.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Bacterial Meningitis</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">7.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;"><sup><span class="fnPage35_ICR" style="font-size: 5px"></span></sup>Angioplasty and Other Invasive Treatments for Major Coronary Artery Disease</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">25.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Major Head Trauma</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">8.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">End Stage Liver Failure</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">26.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Chronic Aplastic Anemia</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">9.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Fulminant Viral Hepatitis</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">27.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Motor Neuron Disease</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">10.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Coma</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">28.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Parkinson's Disease</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">11.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Benign Brain Tumor</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">29.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Alzheimer's Disease/Irreversible Organic Degenerative Brain Disorders</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">12.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Paralysis/Paraplegia</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">30.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Muscular Dystrophy</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">13.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Blindness /Total Loss of Sight</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">31.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Surgery to Aorta</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">14.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Deafness/Total Loss of Hearing</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">32.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Multiple Sclerosis</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">15.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Major Burns</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">33.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Primary Pulmonary Arterial Hypertension</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">16.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">End Stage Lung Disease</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">34.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Medullary Cystic Disease</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">17.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Encephalitis</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">35.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Severe Cardiomyopathy</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">18.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Major Organ / Bone Marrow Transplant</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">36.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Systemic Lupus Erythematosus with Lupus Nephritis</td>
</tr>
</table>
<br/>
<span class="fnPage35_ICR"></span>Benefit payment under this illness is limited to 10% of the Critical Illness coverage under this plan subject to a maximum of RM 25,000. This benefit<br/>
is payable once only and shall be deducted from the coverage of this plan, thereby reducing the benefit payable upon Critical Illness or TPD.
</td>
</tr>
<!--ICR-Income Care Rider end-->

<!--LCPR-Living Care Income Rider start-->
<tr class="LCPR" id="LCPR" style="display:table-row;">
<td class="contentSmall">Living<br/>Care Plus<br/>Rider</td>
<td class="contentSmall" style="text-align:right;"><span id="LCPRRiderGYI" class="LCPRRiderGYI">{LCPRRiderGYI}</span></td>
<td class="contentSmall" style="text-align:center;"><span id="LCPRRiderTerm" class="LCPRRiderTerm">{LCPRRiderGYI}</span></td>
<td class="contentSmall" style="text-align:left;">Life<br/>Assured</td>
<td class="content">

RM <span id=""LCPRGYI class="LCPRGYI">{LCPRGYI}</span> is payable upon the occurrence of death / TPD / diagnosis of any of the 36 critical illnesses of the life assured during the coverage period, whichever is earlier. TPD benefit will be paid in accordance to TPD provision. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br/>
The following 36 critical illnesses are covered:

<table id="illness" class="illness" style="border-collapse:separate;border: 0px solid black;width: 75%;">
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">1.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Stroke</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">19.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Loss of Speech</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">2.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Heart Attack</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">20.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Brain Surgery</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">3.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">End Stage Kidney Failure</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">21.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Heart Valve Surgery</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">4.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Cancer</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">22.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Terminal Illness</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">5.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Coronary Artery By-Pass Surgery</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">23.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">HIV due to Blood Transfusion</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">6.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Other Serious Coronary Artery Disease</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">24.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Bacterial Meningitis</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">7.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;"><sup><span class="fnPage35_LCPR" style="font-size: 5px"></span></sup>Angioplasty and Other Invasive Treatments for Major Coronary Artery Disease</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">25.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Major Head Trauma</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">8.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">End Stage Liver Failure</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">26.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Chronic Aplastic Anemia</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">9.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Fulminant Viral Hepatitis</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">27.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Motor Neuron Disease</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">10.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Coma</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">28.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Parkinson's Disease</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">11.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Benign Brain Tumor</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">29.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Alzheimer's Disease/Irreversible Organic Degenerative Brain Disorders</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">12.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Paralysis/Paraplegia</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">30.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Muscular Dystrophy</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">13.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Blindness /Total Loss of Sight</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">31.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Surgery to Aorta</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">14.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Deafness/Total Loss of Hearing</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">32.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Multiple Sclerosis</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">15.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Major Burns</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">33.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Primary Pulmonary Arterial Hypertension</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">16.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">End Stage Lung Disease</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">34.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Medullary Cystic Disease</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">17.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Encephalitis</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">35.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Severe Cardiomyopathy</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">18.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Major Organ / Bone Marrow Transplant</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">36.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Systemic Lupus Erythematosus with Lupus Nephritis</td>
</tr>
</table>
<br/>
<span class="fnPage35_LCPR"></span>Benefit payment under this illness is limited to 10% of the Critical Illness coverage under this plan subject to a maximum of RM 25,000. This benefit<br/>
is payable once only and shall be deducted from the coverage of this plan, thereby reducing the amount of lump sum payment upon Critical Illness, Death or TPD.
</td>
</tr>
<!--LCPR-Living Carew Income Rider end-->


<!--PA-Personal Accident Rider start-->
<tr class="PA" id="PA" style="display:table-row;">
<td class="contentSmall">Personal<br/>Accident<br/>Rider <span id="OCCPClass" class="OCCPClass">{OCCPClass}</span></td>
<td class="contentSmall" style="text-align:right;"><span id="PARiderGYI" class="PARiderGYI">{PARiderGYI}</span></td>
<td class="contentSmall" style="text-align:center;"><span id="PARiderTerm" class="PARiderTerm">{PARiderTerm}</span></td>
<td class="contentSmall" style="text-align:left;">Life<br/>Assured</td>
<td class="content">

The following benefits are payable during the coverage period:<br/>
-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accidental Death<br/>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i.&nbsp;&nbsp;Death due to Accident  â€“ Rider Sum Assured is payable<br/>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii.&nbsp;&nbsp;Double Indemnity - Rider Sum Assured payable is doubled if accidental death of Life Assured occurred while the Life Assured is on mechanically propelled Public Conveyance over an established route on land, excluding Taxis<br/>
-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total &amp; Permanent Disability due to accident - refer to Schedule of Indemnities in the Rider<br/>
-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compassionate Allowance Benefit - RM500 will be payable in one lump sum in the event of death of the Life Assured due to any cause<br/>

</td>
</tr>
<!--PA-Personal Accident Rider end-->

    
<!--TPDYLA-TPD Yearly Living Allowance Rider start-->
<tr class="TPDYLA" id="TPDYLA" style="display:table-row;">
<td class="contentSmall">TPD Yearly Living <br/>Allowance Rider</td>
<td class="contentSmall" style="text-align:right;"><span id="ETPDRiderGYI" class="ETPDRiderGYI">{ETPDRiderGYI}</span></td>
<td class="contentSmall" style="text-align:center;"><span id="ETPDRiderTerm" class="ETPDRiderTerm">{ETPDRiderTerm}</span></td>
<td class="contentSmall" style="text-align:left;">Life<br/>Assured</td>
<td class="content">
Upon TPD of the Life Assured during the coverage term and the Life Assured remains disabled, RM<span id="ETPDGYI" class="ETPDGYI">{ETPDGYI}</span> shall be payable annually up to age 70 or death of the Life Assured, whichever is earlier. The first payment is on the 1st anniversary subsequent to the commencement of TPD. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</td>
</tr>
<!--TPDYLA-TPD Yearly Living Allowance Rider end-->
    
<!--WA50R-Wealth Advantage Rider starts--> 
<tr class="WA50R" id="WA50R" style="display:table-row;">
    <td class="contentSmall">Wealth<br/>Advantage<br/>Rider</td>
    <td class="contentSmall" style="text-align:right;"><span id="WA50RGYI" class="WA50RGYI">{WA50RGYI}</span></td>
    <td class="contentSmall" style="text-align:center;"><span id="WA50RTerm" class="WA50RTerm">50</span></td>
    <td class="contentSmall" style="text-align:left;">Life<br/>Assured</td>
    <td class="content">
        <b><u>Death/TPD Benefit</b></u> </br>
        ï¿¼In the event of Death/TPD (prior to attaining age 65) of the Life Assured, the Death/TPD benefit payable shall be 100% of total Rider annual premium paid (exclude any loading premium and will be the annual premium sum before any discount), accumulated GYCC (if any), accumulated Cash Dividend (if any) and Special Terminal Dividend (if any).</br></br>
        
        TPD benefit will be paid in accordance to TPD provision as illustrated under Descriptions of Basic Plan Benefits.</br></br>
        
        <b><u>Guaranteed Yearly Cash Coupons (GYCC) Benefit</b></u> </br>
        Increasing Guaranteed Yearly Cash Coupons are payable starting from end of year 1 up to expiry of the rider. The amount of GYCC that is payable during the GYCC payment period are as shown in Table 1 below. </br></br>
        
        Table 1
        <table id="illness" class="illness" width="35%" style="border-collapse: collapse; margin-left: 20px" border="1">
            <tr>
                <td width="30%" align="left">Policy Year</td>
                <td width="70%" style="padding: 0px 0px 0px 5px;">Amount of GYCC Payable</td>
            </tr>
            <tr>
                <td align="left">Year 1</td>
                <td style="padding: 0px 0px 0px 5px;">100% of GYCC amount purchased</td>
            </tr>
            <tr>
                <td align="left">Year 2</td>
                <td style="padding: 0px 0px 0px 5px;">200% of GYCC amount purchased</td>
            </tr>
            <tr>
                <td align="left">Year 3</td>
                <td style="padding: 0px 0px 0px 5px;">300% of GYCC amount purchased</td>
            </tr>
            <tr>
                <td align="left">Year 4</td>
                <td style="padding: 0px 0px 0px 5px;">400% of GYCC amount purchased</td>
            </tr>
            <tr>
                <td align="left">Year 5</td>
                <td style="padding: 0px 0px 0px 5px;">500% of GYCC amount purchased</td>
            </tr>
            <tr>
                <td align="left">Year 6 onwards</td>
                <td style="padding: 0px 0px 0px 5px;">600% of GYCC amount purchased</td>
            </tr>
        </table>
        
        <b><u>Advancement of Future Guaranteed Yearly Cash Coupons (GYCC)</b></u></b>
        Policy Owner may advance the next 5 years' GYCC upon happening of events as listed below; starting from the rider year where the first GYCC is payable and provided that the policy has acquired sufficient net cash surrender value.<br>
        
        -&nbsp;&nbsp; Marriage<br>
        -&nbsp;&nbsp; Child Birth<br>
        -&nbsp;&nbsp; Children's university admission<br>
        -&nbsp;&nbsp; Children's graduation/convocation<br>
        -&nbsp;&nbsp; Children's wedding<br>
        -&nbsp;&nbsp; Purchase of new house<br>
        -&nbsp;&nbsp; Starting of a business<br>
        -&nbsp;&nbsp; Business Disruption<br>
        -&nbsp;&nbsp; Policy Owner/ Parents/ Children admitted to hospital<br>
        -&nbsp;&nbsp; Parent/children death<br>
        -&nbsp;&nbsp; Policy owner diagnosed with critical illness<br>
        -&nbsp;&nbsp; Policy owner suffers temporary total disablement due to illness or accident.<br><br>
        
        The above listed events are not exhaustive and the Company may include more events at its discretion from time to time.<br><br>
        
        The amount payable to Policy Owner shall be 85% of the total next 5 years' GYCC. Thereafter, the GYCC due for the next 5 years immediately following the advancement shall cease to be payable in order to offset the said advancement.<br><br>
        
        
        Upon surrender or Death/TPD claim, the Company before making any payments pursuant to this Policy shall be entitled to deduct any amounts owed to the Company arising from the said advancement, accrued with interest at 5.67% per annum.<br>
    </td>
</tr>
<!--WA50R-Wealth Advantage Rider ends-->   
    
    
<!--WB30R-Wealth Booster Rider starts--> 
<tr class="WB30R" id="WB30R" style="display:table-row;">
    <td class="contentSmall">Wealth Booster<br/>Rider (30 year term)</td>
    <td class="contentSmall" style="text-align:right;"><span id="WB30RGYI" class="WB30RGYI">{WB30RGYI}</span></td>
    <td class="contentSmall" style="text-align:center;"><span id="WB30RTerm" class="WB30RTerm">30</span></td>
    <td class="contentSmall" style="text-align:left;">Life<br/>Assured</td>
    <td class="content">
        <b><u>Death/TPD Benefit</b></u> </br>
        In the event of Death/TPD (prior to attaining age 65) of the Life Assured, the Death/TPD benefit payable shall be 100% of premium paid for this Rider (exclude any loading premium) calculated based on an annual mode of payment, accumulated GYCC (if any), accumulated Cash Dividend (if any) and Special Terminal Dividend (if any).</br></br>
        
        TPD benefit will be paid in accordance to TPD provision as illustrated under Descriptions of Basic Plan Benefits.</br></br>

        
        <b><u>Guaranteed Yearly Cash Coupons (GYCC) Benefit</b></u> </br>
        Guaranteed Yearly Cash Coupons of RM<span id="WB30RGYI" class="WB30RGYI">{WB30RGYI}</span> is payable starting from end of year 1 up to expiry of the rider. </br></br>
        
        <b><u>Advancement of Future Guaranteed Yearly Cash Coupons (GYCC)</u></b><br/>
        Policy Owner may advance the next 5 years' GYCC upon happening of events as listed below; starting from the rider year where the first GYCC is payable and provided that the policy has acquired sufficient net cash surrender value.<br>
        
        -&nbsp;&nbsp; Marriage<br>
        -&nbsp;&nbsp; Child Birth<br>
        -&nbsp;&nbsp; Children's university admission<br>
        -&nbsp;&nbsp; Children's graduation/convocation<br>
        -&nbsp;&nbsp; Children's wedding<br>
        -&nbsp;&nbsp; Purchase of new house<br>
        -&nbsp;&nbsp; Starting of a business<br>
        -&nbsp;&nbsp; Business Disruption<br>
        -&nbsp;&nbsp; Policy Owner/ Parents/ Children admitted to hospital<br>
        -&nbsp;&nbsp; Parent/children death<br>
        -&nbsp;&nbsp; Policy owner diagnosed with critical illness<br>
        -&nbsp;&nbsp; Policy owner suffers temporary total disablement due to illness or accident.<br><br>
        
        The above listed events are not exhaustive and the Company may include more events at its discretion from time to time.<br><br>
        
        The amount payable to Policy Owner shall be 85% of the total next 5 years' GYCC. Thereafter, the GYCC due for the next 5 years immediately following the advancement shall cease to be payable in order to offset the said advancement.<br><br>
        
        
        Upon surrender or Death/ TPD claim, the Company before making any payments pursuant to this Policy shall be entitled to deduct any amounts owed to the Company arising from the said advancement, accrued with interest at 5.67% per annum.<br>
    </td>
</tr>
<!--WB30R-Wealth Booster Rider ends-->     
    
    
<!--WB50R-Wealth Booster Rider starts--> 
<tr class="WB50R" id="WB50R" style="display:table-row;">
    <td class="contentSmall">Wealth Booster<br/>Rider (50 year term)</td>
    <td class="contentSmall" style="text-align:right;"><span id="WB50RGYI" class="WB50RGYI">{WB50RGYI}</span></td>
    <td class="contentSmall" style="text-align:center;"><span id="WB50RTerm" class="WB50RTerm">50</span></td>
    <td class="contentSmall" style="text-align:left;">Life<br/>Assured</td>
    <td class="content">
        <b><u>Death/TPD Benefit</b></u> </br>
        In the event of Death/TPD (prior to attaining age 65) of the Life Assured, the Death/TPD benefit payable shall be 100% of premium paid for this Rider (exclude any loading premium) calculated based on an annual mode of payment, accumulated GYCC (if any), accumulated Cash Dividend (if any) and Special Terminal Dividend (if any).</br></br>
        
        TPD benefit will be paid in accordance to TPD provision as illustrated under Descriptions of Basic Plan Benefits.</br></br>
        
        <b><u>Guaranteed Yearly Cash Coupons (GYCC) Benefit</u></b> </br>
        Guaranteed Yearly Cash Coupons of RM<span id="WB50RGYI" class="WB50RGYI">{WB50RGYI}</span> is payable starting from end of year 1 up to expiry of the rider.</br></br>
        
        <b><u>Advancement of Future Guaranteed Yearly Cash Coupons (GYCC)</u></b></b><br/>
        Policy Owner may advance the next 5 years' GYCC upon happening of events as listed below; starting from the rider year where the first GYCC is payable and provided that the policy has acquired sufficient net cash surrender value.<br>
        
        -&nbsp;&nbsp; Marriage<br>
        -&nbsp;&nbsp; Child Birth<br>
        -&nbsp;&nbsp; Children's university admission<br>
        -&nbsp;&nbsp; Children's graduation/convocation<br>
        -&nbsp;&nbsp; Children's wedding<br>
        -&nbsp;&nbsp; Purchase of new house<br>
        -&nbsp;&nbsp; Starting of a business<br>
        -&nbsp;&nbsp; Business Disruption<br>
        -&nbsp;&nbsp; Policy Owner/ Parents/ Children admitted to hospital<br>
        -&nbsp;&nbsp; Parent/children death<br>
        -&nbsp;&nbsp; Policy owner diagnosed with critical illness<br>
        -&nbsp;&nbsp; Policy owner suffers temporary total disablement due to illness or accident.<br><br>
        
        The above listed events are not exhaustive and the Company may include more events at its discretion from time to time.<br><br>
        
        The amount payable to Policy Owner shall be 85% of the total next 5 years' GYCC. Thereafter, the GYCC due for the next 5 years immediately following the advancement shall cease to be payable in order to offset the said advancement.<br><br>
        
        
        Upon surrender or Death/TPD claim, the Company before making any payments pursuant to this Policy shall be entitled to deduct any amounts owed to the Company arising from the said advancement, accrued with interest at 5.67% per annum.<br>
    </td>
</tr>
<!--WB50R-Wealth Booster Rider ends-->     
    
    
<!--WBD10R30-Wealth Enricher Rider starts--> 
<tr class="WBD10R30" id="WBD10R30" style="display:table-row;">
    <td class="contentSmall">Wealth Booster-<i>d10</i> Rider (30 year term)</td>
    <td class="contentSmall" style="text-align:right;"><span id="WBD10R30GYI" class="WBD10R30GYI">{WE30RGYI}</span></td>
    <td class="contentSmall" style="text-align:center;"><span id="WBD10R30Term" class="WBD10R30Term">30</span></td>
    <td class="contentSmall" style="text-align:left;">Life<br/>Assured</td>
    <td class="content">
        <b><u>Death/TPD Benefit</u></b> </br>
        In the event of Death/TPD (prior to attaining age 65) of the Life Assured, the Death/TPD benefit payable shall be 100% of premium paid for this Rider (exclude any loading premium) calculated based on an annual mode of payment, accumulated GYCC (if any), accumulated Cash Dividend (if any) and Special Terminal Dividend (if any).</br></br>
        
        TPD benefit will be paid in accordance to TPD provision as illustrated under Descriptions of Basic Plan Benefits.</br></br>
        
        <b><u>Guaranteed Yearly Cash Coupons (GYCC) Benefit</u></b> </br>
        Guaranteed Yearly Cash Coupons of RM<span id="WBD10R30GYI" class="WBD10R30GYI">{WBD10R30GYI}</span> is payable starting from end of year 11 up to expiry of the rider.</br></br>
        
        <b><u>Advancement of Future Guaranteed Yearly Cash Coupons (GYCC) </u></b><br/>
        Policy Owner may advance the next 5 years' GYCC upon happening of events as listed below; starting from the rider year where the first GYCC is payable and provided that the policy has acquired sufficient net cash surrender value.<br>
        
        -&nbsp;&nbsp; Marriage<br>
        -&nbsp;&nbsp; Child Birth<br>
        -&nbsp;&nbsp; Children's university admission<br>
        -&nbsp;&nbsp; Children's graduation/convocation<br>
        -&nbsp;&nbsp; Children's wedding<br>
        -&nbsp;&nbsp; Purchase of new house<br>
        -&nbsp;&nbsp; Starting of a business<br>
        -&nbsp;&nbsp; Business Disruption<br>
        -&nbsp;&nbsp; Policy Owner/ Parents/ Children admitted to hospital<br>
        -&nbsp;&nbsp; Parent/children death<br>
        -&nbsp;&nbsp; Policy owner diagnosed with critical illness<br>
        -&nbsp;&nbsp; Policy owner suffers temporary total disablement due to illness or accident.<br><br>
        
        The above listed events are not exhaustive and the Company may include more events at its discretion from time to time.<br><br>
        
        The amount payable to Policy Owner shall be 85% of the total next 5 years' GYCC. Thereafter, the GYCC due for the next 5 years immediately following the advancement shall cease to be payable in order to offset the said advancement.<br><br>
        
        
        Upon surrender or Death/TPD claim, the Company before making any payments pursuant to this Policy shall be entitled to deduct any amounts owed to the Company arising from the said advancement, accrued with interest at 5.67% per annum.<br>
    </td>
</tr>
<!--WBD10R30-Wealth Enricher Rider ends-->      
    
    
<!--WBM6R-Wealth Booster-m6 Rider starts--> 
<tr class="WBM6R" id="WBM6R" style="display:table-row;">
    <td class="contentSmall">Wealth Booster-<i>m6</i> Rider (30 year term)</td>
    <td class="contentSmall" style="text-align:right;"><span id="WBM6RGYI" class="WBM6RGYI">{WBM6RGYI}</span></td>
    <td class="contentSmall" style="text-align:center;"><span id="WBM6RTerm" class="WBM6RTerm">30</span></td>
    <td class="contentSmall" style="text-align:left;">Life<br/>Assured</td>
    <td class="content">
        <b><u>Death/TPD Benefit</u></b> </br>
        In the event of Death/TPD (prior to attaining age 65) of the Life Assured, the Death/TPD benefit payable shall be 100% of total premium paid for this Rider (exclude any loading premium) calculated based on an annual mode of payment, accumulated GMCC (if any), accumulated Cash Dividend (if any) and Special Terminal Dividend (if any).</br></br>
        
        TPD benefit will be paid in accordance to the provision as stated in the policy.</br></br>
        
        <b><u>Guaranteed Monthly Cash Coupons (GMCC) Benefit</u></b> </br>
        Guaranteed Monthly Cash Coupons are payable starting from end of month 6 up to expiry of the rider. The amount of GMCC that is payable during the GMCC payment period are as shown in the table below.</br></br>
        <table id="illness" class="illness" width="60%" style="border-collapse: collapse; margin-left: 20px" border="1">
		<tr>
			<td style="text-align:center"><b>Benefit Payment Term</b></td>
			<td style="text-align:center"><b>GMCC Benefit Payable</b></td>
		</tr>
		<tr>
			<td>End of 6th month to end of 359th month of the term of the rider</td>
			<td>100% of GMCC amount</td>    	
		</tr>
		<tr>
			<td>On the expiry date of the rider</td>
			<td>600% of GMCC amount</td>
		</tr>
		</table><br/>
        
        <b><u>Advancement of Future Guaranteed Monthly  Cash Coupons (GMCC) </u></b><br/>
        Policy Owner may advance the next 5 years' GMCC upon happening of events as listed below; starting from the month where the first GMCC is payable and provided that the policy has acquired sufficient net cash surrender value.<br>
    <ul class="list_left_margin0">
    	<li>-&nbsp;&nbsp; Marriage</li>
    	<li>-&nbsp;&nbsp; Child Birth</li>
    	<li>-&nbsp;&nbsp; Children's university admission</li>
    	<li>-&nbsp;&nbsp; Children's graduation/convocation</li>
    	<li>-&nbsp;&nbsp; Children's wedding</li>
    	<li>-&nbsp;&nbsp; Purchase of new house</li>
    	<li>-&nbsp;&nbsp; Starting of a business</li>
    	<li>-&nbsp;&nbsp; Business Disruption</li>
    	<li>-&nbsp;&nbsp; Policy Owner/ Parents/ Children admitted to hospital</li>
    	<li>-&nbsp;&nbsp; Parent/children death</li>
    	<li>-&nbsp;&nbsp; Policy owner diagnosed with critical illness</li>
    	<li>-&nbsp;&nbsp; Policy owner suffers temporary total disablement due to illness or accident.</li>
    </ul><br/>       
        The above listed events are not exhaustive and the Company may include more events at its discretion from time to time.<br><br>
        
        The amount payable to Policy Owner shall be 87% of the total next 5 years' GMCC. Thereafter, the GMCC due for the next 5 years immediately following the advancement shall cease to be payable in order to offset the said advancement.<br><br>
        
        
        Upon surrender or Death/TPD claim, the Company before making any payments pursuant to this Policy shall be entitled to deduct any amounts owed to the Company arising from the said advancement, accrued with interest at 5.67% per annum.
    </td>
</tr>
<!--WBM6R-Wealth Booster-m6 Rider Rider ends-->    
    
    
<!--WBI6R30Wealth Advantage Rider starts--> 
<tr class="WBI6R30" id="WBI6R30" style="display:table-row;">
    <td class="contentSmall">Wealth Booster-<i>i6</i> Rider (30 year term)</td>
    <td class="contentSmall" style="text-align:right;"><span id="WBI6R30GYI" class="WBI6R30GYI">{WBI6R30GYI}</span></td>
    <td class="contentSmall" style="text-align:center;"><span id="WBI6R30Term" class="WBI6R30Term">30</span></td>
    <td class="contentSmall" style="text-align:left;">Life<br/>Assured</td>
    <td class="content">
        <b><u>Death/TPD Benefit</b></u> </br>
        ï¿¼In the event of Death/TPD (prior to attaining age 65) of the Life Assured, the Death/TPD benefit payable shall be 100% of premium paid for this Rider (exclude any loading premium) calculated based on an annual mode of payment, accumulated GYCC (if any), accumulated Cash Dividend (if any) and Special Terminal Dividend (if any).</br></br>
        
        TPD benefit will be paid in accordance to TPD provision as illustrated under Descriptions of Basic Plan Benefits.</br></br>
        
        <b><u>Guaranteed Yearly Cash Coupons (GYCC) Benefit</b></u> </br>
	Guaranteed Yearly Cash Coupons are payable starting from end of year 1 up to expiry of the rider. The amount of GYCC that is payable during the GYCC payment period are as shown in the table below. </br></br>
        
        <table id="illness" class="illness" width="35%" style="border-collapse: collapse; margin-left: 20px" border="1">
            <tr>
                <td width="30%" align="left">Policy Year</td>
                <td width="70%" style="padding: 0px 0px 0px 5px;">Amount of GYCC Payable</td>
            </tr>
            <tr>
                <td align="left">Year 1</td>
                <td style="padding: 0px 0px 0px 1px;">100% of GYCC amount purchased</td>
            </tr>
            <tr>
                <td align="left">Year 2</td>
                <td style="padding: 0px 0px 0px 1px;">200% of GYCC amount purchased</td>
            </tr>
            <tr>
                <td align="left">Year 3</td>
                <td style="padding: 0px 0px 0px 1px;">300% of GYCC amount purchased</td>
            </tr>
            <tr>
                <td align="left">Year 4</td>
                <td style="padding: 0px 0px 0px 1px;">400% of GYCC amount purchased</td>
            </tr>
            <tr>
                <td align="left">Year 5</td>
                <td style="padding: 0px 0px 0px 1px;">500% of GYCC amount purchased</td>
            </tr>
            <tr>
                <td align="left">Year 6 onwards</td>
                <td style="padding: 0px 0px 0px 1px;">600% of GYCC amount purchased</td>
            </tr>
        </table>
        <br/>
        <b><u>Advancement of Future Guaranteed Yearly Cash Coupons (GYCC)</u></b><br/>
        Policy Owner may advance the next 5 years' GYCC upon happening of events as listed below; starting from the rider year where the first GYCC is payable and provided that the policy has acquired sufficient net cash surrender value.<br>
        
        -&nbsp;&nbsp; Marriage<br>
        -&nbsp;&nbsp; Child Birth<br>
        -&nbsp;&nbsp; Children's university admission<br>
        -&nbsp;&nbsp; Children's graduation/convocation<br>
        -&nbsp;&nbsp; Children's wedding<br>
        -&nbsp;&nbsp; Purchase of new house<br>
        -&nbsp;&nbsp; Starting of a business<br>
        -&nbsp;&nbsp; Business Disruption<br>
        -&nbsp;&nbsp; Policy Owner/ Parents/ Children admitted to hospital<br>
        -&nbsp;&nbsp; Parent/children death<br>
        -&nbsp;&nbsp; Policy owner diagnosed with critical illness<br>
        -&nbsp;&nbsp; Policy owner suffers temporary total disablement due to illness or accident.<br><br/>
    </td>
</tr>
<!--WA30R-Wealth Advantage Rider ends-->     
    
    
<!--WE50R-Wealth Enricher Rider starts--> 
<tr class="WE50R" id="WE50R" style="display:table-row;">
    <td class="contentSmall">Wealth<br/>Enricher<br/>Rider</td>
    <td class="contentSmall" style="text-align:right;"><span id="WE50RGYI" class="WE50RGYI">{WE50RGYI}</span></td>
    <td class="contentSmall" style="text-align:center;"><span id="WE50RTerm" class="WE50RTerm">50</span></td>
    <td class="contentSmall" style="text-align:left;">Life<br/>Assured</td>
    <td class="content">
        <b><u>Death/TPD Benefit</b></u> </br>
        In the event of Death/TPD (prior to attaining age 65) of the Life Assured, the Death/TPD benefit payable shall be 100% of total Rider annual premium paid (exclude any loading premium and will be the annual premium sum before any discount), accumulated GYCC (if any), accumulated Cash Dividend (if any) and Special Terminal Dividend (if any).</br></br>
        
        TPD benefit will be paid in accordance to TPD provision as illustrated under Descriptions of Basic Plan Benefits.</br></br>
        
        <b><u>Guaranteed Yearly Cash Coupons (GYCC) Benefit</b></u> </br>
        Guaranteed Yearly Cash Coupons of RM<span id="WE50RGYI" class="WE50RGYI">{WE50RGYI}</span> is payable starting from end of year 11 up to expiry of the rider. </br></br>
        
        <b><u>Advancement of Future Guaranteed Yearly Cash Coupons </b></u></b>
        Policy Owner may advance the next 5 years' GYCC upon happening of events as listed below; starting from the rider year where the first GYCC is payable and provided that the policy has acquired sufficient net cash surrender value.<br>
        
        -&nbsp;&nbsp; Marriage<br>
        -&nbsp;&nbsp; Child Birth<br>
        -&nbsp;&nbsp; Children's university admission<br>
        -&nbsp;&nbsp; Children's graduation/convocation<br>
        -&nbsp;&nbsp; Children's wedding<br>
        -&nbsp;&nbsp; Purchase of new house<br>
        -&nbsp;&nbsp; Starting of a business<br>
        -&nbsp;&nbsp; Business Disruption<br>
        -&nbsp;&nbsp; Policy Owner/ Parents/ Children admitted to hospital<br>
        -&nbsp;&nbsp; Parent/children death<br>
        -&nbsp;&nbsp; Policy owner diagnosed with critical illness<br>
        -&nbsp;&nbsp; Policy owner suffers temporary total disablement due to illness or accident.<br><br>
        
        The above listed events are not exhaustive and the Company may include more events at its discretion from time to time.<br><br>
        
        The amount payable to Policy Owner shall be 85% of the total next 5 years' GYCC. Thereafter, the GYCC due for the next 5 years immediately following the advancement shall cease to be payable in order to offset the said advancement.<br><br>
        
        
        Upon surrender or Death/TPD claim, the Company before making any payments pursuant to this Policy shall be entitled to deduct any amounts owed to the Company arising from the said advancement, accrued with interest at 5.67% per annum.<br>
    </td>
</tr>
<!--WE50R-Wealth Enricher Rider ends-->   
    
    
<!--WP30R-Wealth Protector Rider starts--> 
<tr class="WP30R" id="WP30R" style="display:table-row;">
    <td class="contentSmall">Wealth<br/>Protector<br/>Rider (30 year term)</td>
    <td class="contentSmall" style="text-align:right;"><span id="WP30RSum" class="WP30RSum">{WP30RSum}</span></td>
    <td class="contentSmall" style="text-align:center;"><span id="WP30RTerm" class="WP30RTerm">30</span></td>
    <td class="contentSmall" style="text-align:left;">Life<br/>Assured</td>
    <td  style="width:80%">
        In the event of Death of the Life Assured, a lump sum amount equivalent to RM<span id="WP30RSum" class="WP30RSum">{WP30RSum}</span> shall be payable.<span style="padding-right:300px"></span><br/>
        Juvenile LIEN rule is applicable.<br/>
    </td>
</tr>
<!--WP30R-Wealth Protector Rider ends-->  


<!--WP50R-Wealth Protector Rider starts--> 
<tr class="WP50R" id="WP50R" style="display:table-row;width:100%">
    <td class="contentSmall">Wealth<br/>Protector<br/>Rider (50 year term)</td>
    <td class="contentSmall" style="text-align:right;"><span id="WP50RSum" class="WP50RSum">{WP50RSum}</span></td>
    <td class="contentSmall" style="text-align:center;"><span id="WP50RTerm" class="WP50RTerm">50</span></td>
    <td class="contentSmall" style="text-align:left;">Life<br/>Assured</td>
    <td class="content" style="width:80%">
        In the event of Death of the Life Assured, a lump sum amount equivalent to RM<span id="WP50RSum" class="WP50RSum">{WP50RSum}</span> shall be payable.<span style="padding-right:300px"></span><br/>
        Juvenile LIEN rule is applicable.
        
    </td>
</tr>
<!--WP50R-Wealth Protector Rider ends-->     
    
    
<!-- WPTPD30R-Wealth Protector (TPD) Rider start-->
<tr class="WPTPD30R" id="WPTPD30R" style="display:table-row;">
    <td class="contentSmall">Wealth<br/>TPD<br/>Protector<br/>Rider (30 year term)</td>
    <td class="contentSmall" style="text-align:right;"><span id="WPTPD30RRiderGYI" class="WPTPD30RRiderGYI">{WPTPD30RRiderGYI}</span></td>
    <td class="contentSmall" style="text-align:center;"><span id="WPTPD30RRiderTerm" class="WPTPD30RRiderTerm">30</span></td>
    <td class="contentSmall" style="text-align:left;">Life<br/>Assured</td>
    <td class="content">
        In the event of Total and Permanent Disability prior to attaining age 65 (TPD) or Old Age Disablement after attaining age 65 (OAD) of the Life Assured, a lump sum amount equivalent to RM<span id="WPTPD30RRiderGYI" class="WPTPD30RRiderGYI">{WPTPD30RRiderGYI}</span> be payable. Juvenile LIEN rule is applicable. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br/>
        <u>Provision for TPD Benefit</u><br/>
        TPD Benefit for this Rider will be paid in accordance to TPD provision as below:<br/><br/>
	
        <table id="illness" class="illness" style="border-collapse:collapse;border: 1px solid black;width: 50%;" >
            <tr>
                <td width="50%" style="text-align:center;">Attained Age upon TPD</td>
                <td width="50%" style="text-align:center;">TPD Benefit Limit per Life</td>
            </tr>
            <tr>
                <td style="text-align:center;">Less than 7</td>
                <td style="text-align:center;">RM100,000</td>
            </tr>
            <tr>
                <td style="text-align:center;">7 to less than 15</td>
                <td style="text-align:center;">RM500,000</td>
            </tr>
            
        </table>
        <br/>
        
        <u>Provision for OAD Benefit</u><br/>
        OAD Benefits payable under this Rider insuring the Life Assured shall limit to RM1,000,000 per life. <br/><br/>
	
        Note: TPD refers to Total & Permanent Disability prior to attaining age 65 and OAD refers to Old Age Disablement after attaining age 65. These definitions<br/>
        apply consistently across all marketing collaterals for Wealth TPD Protector Rider.
        
        
</td>
</tr>
<!--WPTPD30R-Wealth Protector (TPD) Rider  end-->
        
        
<!-- WPTPD50R-Wealth Protector (TPD) Rider start-->
<tr class="WPTPD50R" id="WPTPD50R" style="display:table-row;">
<td class="contentSmall">Wealth<br/>TPD<br/>Protector<br/>Rider (50 year term)</td>
<td class="contentSmall" style="text-align:right;"><span id="WPTPD50RRiderGYI" class="WPTPD50RRiderGYI">{WPTPD50RRiderGYI}</span></td>
<td class="contentSmall" style="text-align:center;"><span id="WPTPD50RRiderTerm" class="WPTPD50RRiderTerm">50</span></td>
<td class="contentSmall" style="text-align:left;">Life<br/>Assured</td>
<td class="content">
    In the event of Total and Permanent Disability prior to attaining age 65 (TPD) or Old Age Disablement after attaining age 65 (OAD) of the Life Assured, a lump sum amount equivalent to RM<span id="WPTPD50RRiderGYI" class="WPTPD50RRiderGYI">{WPTPD50RGYI}</span> be payable. Juvenile LIEN rule is applicable. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br/>
    <u>Provision for TPD Benefit</u><br/>
    TPD Benefit for this Rider will be paid in accordance to TPD provision as below:<br/><br/>
    <table id="illness" class="illness" style="border-collapse:collapse;border: 1px solid black;width: 50%;" >
        <tr>
            <td width="50%" style="text-align:center;">Attained Age upon TPD</td>
            <td width="50%" style="text-align:center;">TPD Benefit Limit per Life</td>
        </tr>
        <tr>
            <td style="text-align:center;">Less than 7</td>
            <td style="text-align:center;">RM100,000</td>
        </tr>
        <tr>
            <td style="text-align:center;">7 to less than 15</td>
            <td style="text-align:center;">RM500,000</td>
        </tr>
        
    </table>
    <br/>
    
    
    <u>Provision for OAD Benefit</u><br/>
    OAD Benefits payable under this Rider insuring the Life Assured shall limit to RM1,000,000 per life.<br/><br/>
    
    Note: TPD refers to Total & Permanent Disability prior to attaining age 65 and OAD refers to Old Age Disablement after attaining age 65. These definitions<br/>
    apply consistently across all marketing collaterals for Wealth TPD Protector Rider.
    
    
</td>
</tr>
<!--WPTPD50R-Wealth Protector (TPD) Rider  end-->
    
<!--SP_PRE-WOP Spouse Rider (Premier) start--> 
<tr class="SP_PRE" id="SP_PRE" style="display:table-row;">
<td class="contentSmall">Waiver of Premium<br/>Spouse<br/>Rider<br/>(Premier) <span id="SP_PRESA" class="SP_PRESA">{SP_PRESA}</span></td>
<td class="contentSmall" style="text-align:right;"><span id="SP_PRERiderGYI" class="SP_PRERiderGYI">{SP_PRERiderGYI}</span><br/>(Annually)</td>
<td class="contentSmall" style="text-align:center;"><span id="SP_PRERiderTerm" class="SP_PRERiderTerm">{SP_PRERiderTerm}</span></td>
<td class="contentSmall" style="text-align:left;">2nd Life<br/>Assured</td>
<td class="content">

The Rider Sum Assured will be paid to reduce future premium up to the expiry date of the Rider upon death / TPD / diagnosis of any of 36 critical illnesses covered of the 2nd life assured during the coverage period. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br/>
The following 36 critical illnesses are covered:<br/><br/>

<table id="illness" class="illness" style="border-collapse:separate;border: 0px solid black;width: 75%;">
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">1.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Stroke</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">19.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Loss of Speech</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">2.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Heart Attack</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">20.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Brain Surgery</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">3.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">End Stage Kidney Failure</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">21.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Heart Valve Surgery</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">4.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Cancer</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">22.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Terminal Illness</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">5.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Coronary Artery By-Pass Surgery</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">23.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">HIV due to Blood Transfusion</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">6.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Other Serious Coronary Artery Disease</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">24.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Bacterial Meningitis</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">7.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;"><sup><span class="fnPage35_SPPRE" style="font-size: 5px"></span></sup>Angioplasty and Other Invasive Treatments for Major Coronary Artery Disease</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">25.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Major Head Trauma</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">8.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">End Stage Liver Failure</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">26.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Chronic Aplastic Anemia</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">9.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Fulminant Viral Hepatitis</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">27.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Motor Neuron Disease</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">10.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Coma</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">28.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Parkinson's Disease</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">11.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Benign Brain Tumor</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">29.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Alzheimer's Disease/Irreversible Organic Degenerative Brain Disorders</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">12.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Paralysis/Paraplegia</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">30.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Muscular Dystrophy</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">13.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Blindness /Total Loss of Sight</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">31.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Surgery to Aorta</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">14.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Deafness/Total Loss of Hearing</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">32.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Multiple Sclerosis</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">15.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Major Burns</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">33.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Primary Pulmonary Arterial Hypertension</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">16.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">End Stage Lung Disease</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">34.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Medullary Cystic Disease</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">17.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Encephalitis</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">35.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Severe Cardiomyopathy</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">18.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Major Organ / Bone Marrow Transplant</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">36.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Systemic Lupus Erythematosus with Lupus Nephritis</td>
</tr>
</table>
<br/>
<span class="fnPage35_SPPRE"></span>Benefit payment under this illness is limited to 10% of the Critical Illness coverage under this plan subject to a maximum of RM 25,000. This benefit is payable<br/>
once only and shall be deducted from the coverage of this plan, thereby reducing the benefit payable upon Critical Illness, Death or TPD.
</td>
</tr>
<!--SP_PRE-WOP Spouse Rider (Premier) end-->

<!--SP_STD-WOP Spouse Rider (Standard) start--> 
<tr class="SP_STD" id="SP_STD" style="display:table-row;">
<td class="contentSmall">Waiver of Premium Spouse Rider<br/>(Standard) <span id="SP_STDSA" class="SP_STDSA">{SP_STDSA}</span></td>

<td class="contentSmall" style="text-align:right;"><span id="SP_STDRiderGYI" class="SP_STDRiderGYI">{SP_STDRiderGYI}</span><br/>(Annually)</td>
<td class="contentSmall" style="text-align:center;"><span id="SP_STDRiderTerm" class="SP_STDRiderTerm">{SP_STDRiderTerm}</span></td>
<td class="contentSmall" style="text-align:left;">2nd Life<br/>Assured</td>
<td class="content">
The Rider Sum Assured will be paid to reduce future premium up to the expiry date of the Rider upon death / TPD of the 2nd life assured during the coverage period. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<br/>

</td>
</tr>
<!--SP_STD-WOP Spouse Rider (Standard) end-->
    
<!--LCWP-Living Care Waiver of Premium Payor Rider start--> 
<tr class="LCWP" id="LCWP" style="display:table-row;">
<td class="contentSmall">Living Care Waiver of<br/>Premium Payor Rider <span id="LCWPSA" class="LCWPSA">{LCWPSA}</span></td>
<td class="contentSmall" style="text-align:center;"><span id="LCWPRRiderGYI" class="LCWPRRiderGYI">{LCWPRRiderGYI}</span><br/>(Annually)</td>
<td class="contentSmall" style="text-align:center;"><span id="LCWPRiderTerm" class="LCWPRiderTerm">{LCWPRiderTerm}</span></td>
<td class="contentSmall" style="text-align:center;"><span id="LCWPInsuredLives" class="LCWPInsuredLives">{LCWPInsuredLives}</span></td>
<td class="content">
The Rider Sum Assured will be paid to reduce future premium up to the expiry date of the Rider upon death / TPD / diagnosis of any of 36 critical illnesses covered of the payor during the coverage period. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br/>
The following 36 critical illnesses are covered:<br/><br/>

<table id="illness" class="illness" style="border-collapse:separate;border: 0px solid black;width: 75%;">
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">1.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Stroke</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">19.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Loss of Speech</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">2.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Heart Attack</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">20.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Brain Surgery</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">3.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">End Stage Kidney Failure</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">21.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Heart Valve Surgery</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">4.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Cancer</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">22.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Terminal Illness</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">5.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Coronary Artery By-Pass Surgery</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">23.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">HIV due to Blood Transfusion</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">6.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Other Serious Coronary Artery Disease</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">24.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Bacterial Meningitis</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">7.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;"><sup><span class="fnPage35_LCWP" style="font-size: 5px"></span></sup>Angioplasty and Other Invasive Treatments for Major Coronary Artery Disease</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">25.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Major Head Trauma</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">8.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">End Stage Liver Failure</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">26.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Chronic Aplastic Anemia</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">9.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Fulminant Viral Hepatitis</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">27.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Motor Neuron Disease</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">10.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Coma</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">28.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Parkinson's Disease</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">11.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Benign Brain Tumor</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">29.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Alzheimer's Disease/Irreversible Organic Degenerative Brain Disorders</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">12.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Paralysis/Paraplegia</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">30.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Muscular Dystrophy</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">13.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Blindness /Total Loss of Sight</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">31.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Surgery to Aorta</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">14.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Deafness/Total Loss of Hearing</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">32.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Multiple Sclerosis</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">15.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Major Burns</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">33.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Primary Pulmonary Arterial Hypertension</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">16.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">End Stage Lung Disease</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">34.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Medullary Cystic Disease</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">17.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Encephalitis</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">35.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Severe Cardiomyopathy</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">18.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Major Organ / Bone Marrow Transplant</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">36.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Systemic Lupus Erythematosus with Lupus Nephritis</td>
</tr>
</table>
<br/>
<span class="fnPage35_LCWP"></span>Benefit payment under this illness is limited to 10% of the Critical Illness coverage under this plan subject to a maximum of RM 25,000. This benefit is<br/>
payable once only and shall be deducted from the coverage of this plan, thereby reducing the benefit payable upon Critical Illness, Death or TPD.
</td>
</tr>
<!--LCWP-Living Care Waiver of Premium Payor Rider end-->

<!--PR-Waiver of Premium Payor Rider start--> 
<tr class="PR" id="PR" style="display:table-row;">
<td class="contentSmall">Waiver of<br/>Premium<br/>Payor Rider <span id="PRSA" class="PRSA">{PRSA}</span></td>
<td class="contentSmall" style="text-align:right;"><span id="PRRiderGYI" class="PRRiderGYI">{PRRiderGYI}</span><br/>(Annually)</td>
<td class="contentSmall" style="text-align:center;"><span id="PRRiderTerm" class="PRRiderTerm">{PRRiderTerm}</span></td>
<td class="contentSmall" style="text-align:left;"><span id="PRInsuredLives" class="PRInsuredLives">{PRInsuredLives}</span></td>
<td class="content">
The Rider Sum Assured will be paid to reduce future premium up to the expiry date of the Rider upon death / TPD of the payor during the coverage period. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</td>
</tr>
<!--PR-Waiver of Premium Payor Rider end-->


<!--PLCP-Payor Living Care PLus Rider start--> 
<tr class="PLCP" id="PLCP" style="display:table-row;">
<td class="contentSmall">Payor<br/>Living Care<br/>Plus Rider</td>
<td class="contentSmall" style="text-align:right;"><span id="PLCPRiderGYI" class="PLCPRiderGYI">{PLCPRiderGYI}</span></td>
<td class="contentSmall" style="text-align:center;"><span id="PLCPRiderTerm" class="PLCPRiderTerm">{PLCPRiderTerm}</span></td>
<td class="contentSmall" style="text-align:left;">Policy Owner</td>
<td class="content">
RM <span id="PLCPRiderGYI" class="PLCPRiderGYI">{PLCPRiderGYI}</span> is payable upon the occurrence of death / TPD / diagnosis of any of the 36 critical illnesses of the payor during the coverage period, whichever is earlier. TPD benefit will be paid in accordance to TPD provision.<br/>
The following 36 critical illnesses are covered:<br/><br/>



<table id="illness" class="illness" style="border-collapse:separate;border: 0px solid black;width: 75%;">
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">1.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Stroke</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">19.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Loss of Speech</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">2.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Heart Attack</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">20.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Brain Surgery</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">3.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">End Stage Kidney Failure</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">21.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Heart Valve Surgery</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">4.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Cancer</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">22.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Terminal Illness</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">5.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Coronary Artery By-Pass Surgery</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">23.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">HIV due to Blood Transfusion</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">6.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Other Serious Coronary Artery Disease</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">24.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Bacterial Meningitis</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">7.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;"><sup><span class="fnPage35_PLCP" style="font-size: 5px"></span></sup>Angioplasty and Other Invasive Treatments for Major Coronary Artery Disease</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">25.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Major Head Trauma</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">8.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">End Stage Liver Failure</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">26.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Chronic Aplastic Anemia</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">9.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Fulminant Viral Hepatitis</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">27.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Motor Neuron Disease</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">10.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Coma</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">28.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Parkinson's Disease</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">11.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Benign Brain Tumor</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">29.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Alzheimer's Disease/Irreversible Organic Degenerative Brain Disorders</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">12.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Paralysis/Paraplegia</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">30.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Muscular Dystrophy</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">13.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Blindness /Total Loss of Sight</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">31.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Surgery to Aorta</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">14.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Deafness/Total Loss of Hearing</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">32.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Multiple Sclerosis</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">15.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Major Burns</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">33.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Primary Pulmonary Arterial Hypertension</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">16.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">End Stage Lung Disease</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">34.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Medullary Cystic Disease</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">17.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Encephalitis</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">35.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Severe Cardiomyopathy</td>
</tr>
<tr>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">18.</td>
<td width="50%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Major Organ / Bone Marrow Transplant</td>
<td width="4%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">36.</td>
<td width="42%" style="padding: 0px 0px 1px 0px;text-align:left;border: 0px solid black;vertical-align: text-top;">Systemic Lupus Erythematosus with Lupus Nephritis</td>
</tr>
</table>
<br/>
<span class="fnPage35_PLCP"></span>Benefit payment under this illness is limited to 10% of the Critical Illness coverage under this plan subject to a maximum of RM 25,000. This benefit is payable<br/>
once only and shall be deducted from the coverage of this plan, thereby reducing the amount of lump sum payment upon Critical Illness, Death or TPD.
</td>
</tr>
<!--PLCP-Payor Living Care PLus Rider end-->

<!--PTR-Payor Term Rider start--> 
<tr class="PTR" id="PTR" style="display:table-row;">
<td class="contentSmall">Payor Term<br/>Rider</td>
<td class="contentSmall" style="text-align:center;"><span id="PTRRiderGYI" class="PTRRiderGYI">{PTRRiderGYI}</span></td>
<td class="contentSmall" style="text-align:center;"><span id="PTRRiderTerm" class="PTRRiderTerm">{PTRRiderTerm}</span></td>
<td class="contentSmall" style="text-align:left;">Policy Owner</td>
<td class="content">
RM <span id="PTRGYI" class="PTRGYI">{PTRGYI}</span> is payable upon  death / TPD (prior to age 65) of the payor during the coverage period. TPD benefit will be paid in accordance to TPD provision. <br/>

</td>
</tr>
<!--PTR-Payor Term Rider end-->




</table>
			
			
			
			</td>
		</table>
	    </td>
	    <br/>
	</tr>
    </table>
</div>

<table border="0" style="border-collapse:separate;border:0px solid black;width:100%;">
<tr>
<td width="75%" style="font-family:Times New Roman;font-size:9.5px;font-weight:normal;padding: 0px 0px 0px 0px;">
This Product Disclosure Sheet consists of <span class="totalPages">{totalPages}</span> pages and each page forms an integral part of the Product Disclosure Sheet. A prospective policy owner is advised to read and
understand the information printed on each and every page.<br/>
<b><span id="rptVersion" class="rptVersion">{rptVersion}</span></b> <br/>
Level 3, Tower B, PJ City Development, No. 15A Jalan 219, Seksyen 51A, 46100 Petaling Jaya, Selangor. Tel: 03-7650 1818 Fax: 03-7650 1991 Website: www.hla.com.my<br/>
</td>
<td width="10%" align="left" valign="bottom" style="padding: 0px 0px 0px 0px;font-family:Times New Roman;font-size:9.5px;font-weight:normal;">Page <span class="currentPage">22</span> of <span class="totalPages">56</span></td>
<td width="15%" align="right" valign="bottom" style="padding: 0px 0px 0px 0px;font-family:Times New Roman;font-size:9.5px;font-weight:normal;">Ref: <span id=SICode class="SICode">{SINo}</span></td>
</tr>
</table>

<script>
$('#table-attachingRider1 tr').css('display','none');
</script>
</div>
</body>
</html>